Aidoc
PrivateLast Round
Series E
Apr 29, 2026
Est. Valuation
$1.2B
Total Funding Raised
$560M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Aidoc is a healthcare technology company that develops AI-powered solutions for medical imaging analysis to assist physicians in detecting and triaging acute abnormalities.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aidoc Comparables
Compare Aidoc with similar companies based on industry and business-model similarity.
Aidoc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Apr 29, 2026 | ||||
| Growth Equity | Jul 23, 2025 | ||||
| Strategic | Jan 21, 2025 | ||||
| Series D Extension | Nov 27, 2023 | ||||
| Series D | Jun 16, 2022 | ||||
Series C | Jul 13, 2021 |
Secondary Market Activity
Bids, offers, and trades by month
| Operation | Date | Price | Size | Share Class | Structure |
|---|---|---|---|---|---|
OFFER |
Key People
Founding team and executive leadership
Aidoc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SoftBank Investment Advisers | Series E |
| Emerge | Series A, Series B |
| TCV | Growth Equity, Series D |
| Jibe Ventures | Growth Equity, Series C |
| Magma Venture Partners | Series C, Series A, Series B, Series D, Growth Equity, Series E |
| SoftBank Group | Series E |
| NVentures | Growth Equity, Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
$150M round led by Goldman Sachs Alternatives
- Apr 21, 2026
Partnered with Sol Radiology to serve Southern California facilities.
Recent news
Latest coverage and updates
- is_developingSep 23, 2026
Aidoc is developing radiology workflow solutions.
- partners_withAug 16, 2026
Aidoc partnered with Riverain Technologies on Jul 1st '25.
- is_developingAug 16, 2026
Aidoc is developing First Read for Chest X-ray on Aug 16th '26.
Aidoc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aidoc's valuation, stock price, and market status.
Is AIdoc a public or private company?
AIdoc is a private company.
What is the current stock price of AIdoc?
AIdoc is a private company with no public stock price. No recent secondary market data is available.
How much is AIdoc worth (valuation)?
AIdoc's valuation is estimated at $1.2B based on funding round data.
Can I buy AIdoc stock?
AIdoc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AIdoc's last funding round?
AIdoc's most recent funding round was Series E on June 16, 2022.
Who are the main investors in AIdoc?
Key investors in AIdoc include TCV, Alpha Intelligence Capital, TCV, TLV Partners, Goldman Sachs Growth Equity.
Will AIdoc IPO soon?
No public IPO plans have been announced for AIdoc.
How can I track AIdoc secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AIdoc's secondary market activity and sign up for updates.